COVID-19 Clinical Trial
Official title:
Short-term Physical Function Outcomes in Severe COVID-19 Patients Admitted to ICU for Invasive Mechanical Ventilation: an Observational Cohort Study
| NCT number | NCT04400461 |
| Other study ID # | 165/20 |
| Secondary ID | |
| Status | Completed |
| Phase | |
| First received | |
| Last updated | |
| Start date | May 15, 2020 |
| Est. completion date | March 1, 2021 |
Little is known about the physical function outcomes in patients with severe COVID-19 patients who are admitted to Intensive Care Unit (ICU) for invasive mechanical ventilation. The purpose of this study is to evaluate the short-term impact on physical function before hospital discharge in subjects with severe COVID-19 who have survived ICU admission for invasive mechanical ventilation.
| Status | Completed |
| Enrollment | 71 |
| Est. completion date | March 1, 2021 |
| Est. primary completion date | February 25, 2021 |
| Accepts healthy volunteers | |
| Gender | All |
| Age group | 18 Years to 80 Years |
| Eligibility | Inclusion Criteria: - subjects diagnosed with COVID-19 who have required admission to ICU for invasive mechanical ventilation; - have received invasive ventilation > 24 hours; - have been successfully weaned from mechanical ventilation > 48 hours; - were independently able to mobilise prior to current hospital admission (this includes subjects who used a walking stick or another gait aid to mobilise. Exclusion Criteria: - subjects or proxies with inability to communicate in Spanish fluently; - cognitive impairment prior to ICU admission; - proven neurological impairment or neuromuscular disorder; - Cerebrovascular Accident during hospital stay; - previous organ transplant; - pregnancy; - unstable fractures or any other injuries that would require medical bed rest. |
| Country | Name | City | State |
|---|---|---|---|
| Spain | Medical ICU. Hospital Universitario Ramón y Cajal | Madrid | |
| Spain | Surgical ICU. Hospital Universitario Ramón y Cajal | Madrid |
| Lead Sponsor | Collaborator |
|---|---|
| Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal |
Spain,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Medical Research Council sum score (MRC- SS). | Physical examination will be performed to carry out manual muscle testing of strength in 6 different muscle groups of the upper limb and lower limb on both sides of the body. | < 48 hours before ICU discharge | |
| Primary | Medical Research Council sum score (MRC- SS). | Physical examination will be performed to carry out manual muscle testing of strength in 6 different muscle groups of the upper limb and lower limb on both sides of the body. | < 24 hours before hospital discharge | |
| Primary | The Functional Status Score for the ICU (FSS-ICU) | The Functional Status Score for the ICU (FSS-ICU) will be used to evaluate 5 functional tasks. Each task is evaluated using an 8-point ordinal scale ranging from 0 (not able to perform) to 7 (complete independence).The total FSS-ICU score ranges from 0 to 35, with higher scores indicating better physical functioning. | < 24 hours before hospital discharge | |
| Secondary | Age | Age in years | Through study completion, up to 6 months | |
| Secondary | Sex | Male vs Female | Throughout study completion , up to 6 month | |
| Secondary | Body Mass Index | kg/m2 | Throughout study completion, up to 6 months | |
| Secondary | Baseline mobility | Baseline mobility | First day the patient can cooperate with assessment according to the ' 5 Standard Questions' test. | |
| Secondary | APACHE II score | Acute Physiology and Chronic Health Evaluation II score.The APACHE II score ranges from 0 to 71 points. Higher scores correspond to more severe disease and a higher risk of death. | <24 hours after ICU admission | |
| Secondary | Length of stay in ICU | Number of days of stay in ICU | Throughout the study completion, up to 6 months | |
| Secondary | Number of days on mechanical ventilation | Number of days on mechanical ventilation | Throughout the study completion, up to 6 months | |
| Secondary | Polyneuropathy diagnosis | Clinical or EMG polyneuropathy diagnosis confirmation | Throughout the study completion, up to 6 months | |
| Secondary | Number of days on Neuromuscular Blockers | Number of days on NMB during mechanical ventilation | Throughout the study completion, up to 6 months | |
| Secondary | Episodes of prone positioning | Number of prone positioning episodes during ICU stay | Throughout the study completion, up to 6 months | |
| Secondary | Length of stay in hospital | Total number of days admitted to hospital | Throughout the study completion, up to 6 months | |
| Secondary | Continuation of care | Home with no follow-up physiotherapy, home with domiciliary or out-patient physiotherapy, rehabilitation facility, care home, transfer to another acute hospital. | Throughout the study completion, up to 6 months |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT06065033 -
Exercise Interventions in Post-acute Sequelae of Covid-19
|
N/A | |
| Completed |
NCT06267534 -
Mindfulness-based Mobile Applications Program
|
N/A | |
| Completed |
NCT05047601 -
A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection
|
Phase 2/Phase 3 | |
| Recruiting |
NCT04481633 -
Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection
|
N/A | |
| Recruiting |
NCT05323760 -
Functional Capacity in Patients Post Mild COVID-19
|
N/A | |
| Completed |
NCT04612972 -
Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru
|
Phase 3 | |
| Completed |
NCT04537949 -
A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05494424 -
Cognitive Rehabilitation in Post-COVID-19 Condition
|
N/A | |
| Active, not recruiting |
NCT06039449 -
A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2
|
Phase 3 | |
| Enrolling by invitation |
NCT05589376 -
You and Me Healthy
|
||
| Completed |
NCT05158816 -
Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
|
||
| Recruiting |
NCT04341506 -
Non-contact ECG Sensor System for COVID19
|
||
| Completed |
NCT04512079 -
FREEDOM COVID-19 Anticoagulation Strategy
|
Phase 4 | |
| Completed |
NCT04384445 -
Zofin (Organicell Flow) for Patients With COVID-19
|
Phase 1/Phase 2 | |
| Completed |
NCT05975060 -
A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants.
|
Phase 2/Phase 3 | |
| Active, not recruiting |
NCT05542862 -
Booster Study of SpikoGen COVID-19 Vaccine
|
Phase 3 | |
| Terminated |
NCT05487040 -
A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease
|
Phase 1 | |
| Withdrawn |
NCT05621967 -
Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation
|
N/A | |
| Terminated |
NCT04498273 -
COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80
|
Phase 3 | |
| Active, not recruiting |
NCT06033560 -
The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure
|